Has Makoto Nishimura, MD received payments from drug or device companies?

Yes. Drug and device makers reported $191,925 in general payments to Makoto Nishimura, MD across 292 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Makoto Nishimura, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Makoto Nishimura, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Makoto Nishimura, MD

Gastroenterology · New York, NYNPI 1083105290

Payments from drug & device makers

What this record shows

This record is dominated by education: $121,538 of the $191,925 with a category attached, or 63.3%. Olympus Corporation Of The Americas accounts for 70.1% of it on its own, with 13 other manufacturers making up the rest. Among gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$191,925in general payments, 2019–2025

Across 292 payments — averaging $657.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Olympus Corporation Of The Americas$135K
Boston Scientific$44K
Olympus Medical Systems Corporation$5K
Olympus Corporation$2K
Lumendi LLC$1K
Takeda Pharmaceutical Company, Limited$1K
plus $3K from 8 others

$195,775in research payments, 2019–2025

Across 2 payments — averaging $97,888 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$196K

What the payments were for

Consulting fees$22,23812%
Speaking & faculty fees$27,03014%
Travel & lodging$12,4496%
Food & beverage$8,2754%
Education$121,53863%
Entertainment$3960%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Olympus Corporation Of The Americas	198	$134,584
Boston Scientific	68	$44,178
Olympus Medical Systems Corporation	3	$4,778
Olympus Corporation	2	$2,153
Lumendi LLC	4	$1,418
Takeda Pharmaceutical Company, Limited	1	$1,338
Takeda Pharmaceuticals U.S.A., Inc.	1	$1,338
Cook Medical LLC	6	$574
Steris Corporation	3	$513
Shimadzu Precision Instruments, Inc.	1	$396
Lilly USA, LLC	2	$250
Fujifilm Healthcare Americas Corporation	1	$154
Medtronic	1	$150
Creo Medical Inc.	1	$104

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Single Use Electrosurgical Knife KD-655$125,943
DISPOSABLE DISTAL ATTACHMENT$110,660
Olympus$103,157
Single Use Repositionable Clip$30,390
Long Clip$18,042
ORISE$16,163
VISIGLIDE$10,290
Single Use Aspiration Needle NA-U200H$9,875
Single Use Electrosurgical Hemostatic Forceps$6,898
GENERAL - THERAPIES$5,266
RESOLUTION CLIP$2,167
DiLumen$1,354
GENERAL HEMOSTASIS$636
TRUFREEZE$411
AXIOS$268
GENERAL - BILIARY DEVICES$265
OMVOH$250
Resolution 360 Clip$174
Hemospray$156
ECHOTIP INSIGHT$155

How this compares

$191,925 in reported general payments places this provider in the 95th percentile of 1,682 gastroenterology providers in New York.

See all gastroenterology providers in New York →

Medicare billing

Part B allowed, 2024

$143,622

Medicare patients

404

Services billed

871

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	69	$1,097
Omeprazole	55	$525

Paid to pharmacies, not to this prescriber.

Other gastroenterology in New York

David Carr LockeNew York$2M
Arthur KornbluthNew York$1.9M
Sonal KumarNew York$1M
David PoppersNew York$939K
Ellen ScherlNew York$857K
Bruce SandsNew York$810K
Jean Frederick ColombelNew York$786K
Seth GrossNew York$624K
Caterina Oneto ArayaNew York$610K
Dana LukinNew York$491K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →